Missouri – Harbor Healthcare Mergers & Acquisitions, a leading advisory firm specializing in compounding pharmacy transactions, is pleased to announce the successful sale of a 50,000 sqft 503A non-sterile compounding pharmacy, to a nationwide strategic acquirer. The transaction marks an important step in expanding the buyer’s operational capacity and capabilities, enabling broader geographic reach and enhanced service to an increasing provider base via the 50-state licensed, non-sterile USP 800 accredited facility.
The pharmacy’s adept team of pharmacists, technicians and specialists, built a strong reputation for delivering high-quality, patient-specific compounded medications. The business represents a state-of-the-art facility that harmonizes technology and software to provide efficient pharmaceutical services to customers and patients.
Mark Alford, Managing Director at Harbor Healthcare, expressed his enthusiasm for the transaction, saying, “M&A activity in the compounding pharmacy market is very active at the moment and sellers are presented with rare opportunities to create generational wealth. Sterile and non-sterile pharmacies are both in high demand and numerous buyers are actively seeking acquisitions. This pharmacy played a critical role in the compounding space, and the acquisition will allow the buyer to continue that legacy while expanding their operational capabilities and customer reach.”
The buyer also shared their excitement, stating, “This acquisition is a key milestone in our strategy to increase capacity and serve a broader range of providers and patients in new markets. We are excited to integrate the business staff and facility into our operations and continue to exceed the high standards of care patients deserve.”
About Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm founded in 1995. Harbor offers a variety of M&A advisory services to middle market healthcare and pharmacy businesses. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, infusion, compounding and 340B pharmacies. Harbor offers regulatory and advisory expertise while maintaining business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions